SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Lee June

(Last) (First) (Middle)
C/O MYOKARDIA, INC.
333 ALLERTON AVENUE

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MyoKardia Inc [ MYOK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Development Officer
3. Date of Earliest Transaction (Month/Day/Year)
05/02/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/02/2018 M 5,457 A $11.95 9,610 D
Common Stock 05/09/2018 M 4,500 A $11.95 14,110 D
Common Stock 05/31/2018 M 364 A $11.95 14,474 D
Common Stock 07/10/2018 M 364 A $11.95 14,838 D
Common Stock 08/09/2018 M 363 A $11.95 15,201 D
Common Stock 09/04/2018 M 364 A $11.95 15,565 D
Common Stock 10/01/2018 M 364 A $11.95 15,929 D
Common Stock 10/11/2018 M 2,500 A $11.95 18,429 D
Common Stock 11/06/2018 M 364 A $11.95 18,793 D
Common Stock 12/03/2018 M 364 A $11.95 19,157 D
Common Stock 02/25/2019 M 3,000 A $11.95 22,157 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $11.95 05/02/2018 M 5,457 (1) 01/31/2027 Common Stock 5,457 $0.00 110,160 D
Stock Option (Right to Buy) $11.95 05/09/2018 M 4,500 (1) 01/31/2027 Common Stock 4,500 $0.00 105,660 D
Stock Option (Right to Buy) $11.95 05/31/2018 M 364 (1) 01/31/2027 Common Stock 364 $0.00 105,296 D
Stock Option (Right to Buy) $11.95 07/10/2018 M 364 (1) 01/31/2027 Common Stock 364 $0.00 104,932 D
Stock Option (Right to Buy) $11.95 08/09/2018 M 363 (1) 01/31/2027 Common Stock 363 $0.00 104,569 D
Stock Option (Right to Buy) $11.95 09/04/2018 M 364 (1) 01/31/2027 Common Stock 364 $0.00 104,205 D
Stock Option (Right to Buy) $11.95 10/01/2018 M 364 (1) 01/31/2027 Common Stock 364 $0.00 103,841 D
Stock Option (Right to Buy) $11.95 10/11/2018 M 2,500 (1) 01/31/2027 Common Stock 2,500 $0.00 101,341 D
Stock Option (Right to Buy) $11.95 11/06/2018 M 364 (1) 01/31/2027 Common Stock 364 $0.00 100,977 D
Stock Option (Right to Buy) $11.95 12/03/2018 M 364 (1) 01/31/2027 Common Stock 364 $0.00 100,613 D
Stock Option (Right to Buy) $11.95 02/25/2019 M 3,000 06/28/2018 01/31/2027 Common Stock 3,000 $0.00 3,250(2) D
Explanation of Responses:
1. 25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
2. On February 1, 2017, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option.
Remarks:
/s/ Cynthia J. Ladd, as Attorney-in-Fact 10/29/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.